r37980778c78--9ddf576d62681bd56249470539bb6ae6

BackgroundPrimaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable point-of-care G6PD diagnostic tests.ObjectivesTo evaluate the performance of the CareStartâ„¢ rapid diagnostic test (RDT) in the hands of healthcare workers (HCWs) and village malaria workers (VMWs) in field settings, and to better understand user perceptions about the risks and benefits of PQ treatment guided by RDT results.MethodsThis study enrolled 105 HCWs and VMWs, herein referred to as trainees, who tested 1,543 healthy adult male volunteers from 84 villages in Cambodia. The trainees were instructed on G6PD screening, primaquine case management, and completed pre and post-training questionnaires. Each trainee tested up to 16 volunteers in the field under observation by the study staff.ResultsOut of 1,542 evaluable G6PD volunteers, 251 (16.28%) had quantitative enzymatic activity less than 30% of an adjusted male median (8.30 U/g Hb). There was no significant difference in test sensitivity in detecting G6PDd between trainees (97.21%), expert study staff in the field (98.01%), and in a laboratory setting (95.62%) (p = 0.229); however, test specificity was different for trainees (96.62%), expert study staff in the field (98.14%), and experts in the laboratory (98.99%) (p < 0.001). Negative predictive values were not statistically different for trainees, expert staff, and laboratory testing: 99.44%, 99.61%, and 99.15%, respectively. Knowledge scores increased significantly post-training, with 98.7% willing to prescribe primaquine for P.vivax malaria, an improvement from 40.6% pre-training (p < 0.001).ConclusionThis study demonstrated ability of medical staff with different background to accurately use CareStartâ„¢ RDT to identify G6PDd in male patients, which may enable safer prescribing of primaquine; however, pharmacovigilance is required to address possible G6PDd misclassifications.

Tags
Data and Resources
To access the resources you must log in

This item has no data

Identity

Description: The Identity category includes attributes that support the identification of the resource.

Field Value
PID https://www.doi.org/10.1371/journal.pone.0228207
URL https://figshare.com/articles/Evaluation_of_the_CareStart_glucose-6-phosphate_dehydrogenase_G6PD_rapid_diagnostic_test_in_the_field_settings_and_assessment_of_perceived_risk_from_primaquine_at_the_community_level_in_Cambodia/11779755
URL http://dx.doi.org/10.1371/journal.pone.0228207
Access Modality

Description: The Access Modality category includes attributes that report the modality of exploitation of the resource.

Field Value
Access Right Open Access
Publishing

Description: Attributes about the publishing venue (e.g. journal) and deposit location (e.g. repository)

Field Value
Collected From figshare
Hosted By figshare
Publication Date 2020-01-31
Additional Info
Field Value
Language UNKNOWN
Resource Type Dataset
system:type dataset
Management Info
Field Value
Source https://science-innovation-policy.openaire.eu/search/dataset?datasetId=r37980778c78::9ddf576d62681bd56249470539bb6ae6
Author jsonws_user
Last Updated 1 January 2021, 16:56 (CET)
Created 1 January 2021, 16:56 (CET)